Vincenzo Zucchi S.p.A. (0DFF)
London Exchange · UK · prices in GBP · close of 23 Oct 2026
Key indicators
| Last close | GBP 1.840 |
|---|---|
| 52-week range | 0.610 – 1.840 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | +0.0% / +0.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 52 |
| Volatility (1 year) | 156.1% |
| Worst drawdown (1 year) | -66.8% |
| Average daily value traded | 0.00M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vincenzo Zucchi is an Italian textile company that makes household linens, including bed sheets, pillowcases, towels and table linens. It designs and produces these goods for the home, supplying retail customers and consumers through its own brands and private-label arrangements. The company is based in Italy, where its textile operations and brand portfolio are centred, and it serves households and retail partners with everyday home textile products.
The shares are listed on the London Exchange in UK under the code 0DFF, and the price on this page is in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vincenzo Zucchi S.p.A. (0DFF) trades on the London Exchange in UK. It last closed at GBP 1.840 on 23 October 2026.
Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 2,925 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.0% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.3% | ||
| From 52-week high | 0.0% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 0.0% | ||
| Stability (higher is calmer) | 6 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 156.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -66.8% | ||
| Liquidity | 1 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M GBP | ||
| Zero-volume days | 100.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | +0.0% |
| 1 year | +0.0% |
| 3 years | +0.0% |
| 5 years | +0.3% |
Signals
| 50-day / 200-day average | 1.840 / 1.834 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.000 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Jul 2023 | GBX 0.0012 |
| 23 Dec 2022 | GBX 0.0008 |
| 29 Apr 2022 | GBX 0.0024 |
| 7 Feb 2022 | GBX 0.0011 |
| 28 Dec 2020 | GBX 0.0012 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.